|
|
|
|
|
|
Intersect Ent Cmn (XENT)
|
|
26.95 +0.30 (+1.13%)
|
6/22/2017 12:09pm
|
|
Open:
|
26.75
|
Pre. Close:
|
26.65
|
|
High:
|
27.25
|
Low:
|
26.35
|
|
Volume:
|
127,972
|
Market Cap:
|
775.41M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
27.32 - 27.81
|
27.81 - 28.8
|
|
Low:
|
25.42 - 25.72
|
25.72 - 26.31
|
|
Close:
|
26 - 26.55
|
26.55 - 27.65
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-21 4:37:56 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 32.68 One year: 38.17
|
|
Support:
|
Support1: 23.94 Support2: 21.45
|
|
Resistance:
|
Resistance1:
27.98 Resistance2: 32.68
|
|
Pivot:
|
26.32 
|
|
Moving Averages:
|
MA(5): 26.50  MA(20): 25.70
MA(100): 18.49 MA(250): 15.68
|
|
MACD:
|
MACD(12,26):
1.20 Signal(12,26,9): 1.36
|
|
%K %D:
|
%K(14,3): 67.18 %D(3): 66.45
|
|
RSI:
|
RSI(14): 63.51
|
|
52-Week:
|
High: 27.98
Low: 7.65 Change(%): 103.4
|
|
Average Vol(K):
|
3-Month: 397
10-Days 421
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.XENT has closed below upper band by 34.4%. Bollinger Bands are 42.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to XENT's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Fri, 24 Feb 2017 13:00:53 GMT
Intersect ENT Announces FDA Approval of Newest Steroid Releasing Implant, PROPEL
Thu, 22 Jun 2017 14:15:00 GMT
Intersect ENT Inc (XENT) Seeing Increased Action in Session
Thu, 22 Jun 2017 15:00:00 GMT
Zacks: Brokerages Anticipate Intersect ENT, Inc. (XENT) Will Announce Earnings ...
Wed, 03 May 2017 18:44:36 GMT
Why Intersect ENT Shares Are Rallying 17% Today
Wed, 02 Nov 2016 16:52:30 GMT
Why Intersect ENT Shares Are Crashing 43% Today
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
